EU earnings analysis
What we found in EU's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
Q2 revenue grew sharply year over year to $15.696 million, but the improvement was offset by higher purchased-uranium costs, resulting in a negative 16.4% gross margin, a $29.495 million operating loss and a $0.21 diluted EPS loss. Liquidity weakened materially as first-half operating cash use reached $42.502 million and cash declined to $21.811 million, prompting a new potential $250.000 million equity offering. Permitting progress at Dewey Burdock and Upper Spring Creek provides operational support, but management acknowledged reduced 2026 production estimates, ongoing permitting delays and persistent internal-control weaknesses.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Uranium Sales Increased 328%
- Q2 revenue increased to $15.696 million from $3.664 million year over year, a $12.032 million or 328% increase, driven by uranium volumes sold rising to 215,000 pounds from 60,000 pounds and realized pricing increasing 20% to $73.00 per pound from $61.07.
- First-Half Sales Growth
- Six-month revenue rose 55% to $33.997 million from $21.904 million, with volumes sold increasing 39% to 485,000 pounds and the realized sales price rising 12% to $70.10 per pound.
- Dewey Burdock Permitting Progress
- Dewey Burdock received BLM approval on June 15, 2026, and the NRC issued a renewed 20-year source materials license on June 30, 2026; the company stated these actions were completed four days ahead of the FAST-41 scheduled completion date.
- South Texas Capacity Expansion
- The Upper Spring Creek-Brown satellite facility completed its first construction phase in May 2026 with 1,600 gallons-per-minute capacity, or 50% of planned capacity; the first wellfield was completed and was awaiting final authorization.
- Substantial Marketable Securities
- Marketable securities totaled $52.221 million at June 30, 2026, including $36.530 million of Verdera equity received in the mineral-property sale, compared with $43.591 million at December 31, 2025.
- Warrant Proceeds Supported Liquidity
- The company generated $17.947 million of financing cash flow in the first six months, primarily from warrant exercises, including $17.798 million of warrant-exercise proceeds.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- Purchased Uranium Caused Negative Margin
- Q2 gross profit was negative $2.576 million, producing a gross margin of approximately negative 16.4%, versus $1.130 million of gross profit and a 30.8% gross margin in Q2 2025. Weighted average cost was $84.99 per pound versus a realized price of $73.00, reflecting greater reliance on higher-cost purchased uranium.
- Rapid Cash Consumption
- Net cash used in operating activities increased to $42.502 million in the first six months from $17.629 million in the prior-year period, while cash and cash equivalents fell to $21.811 million from $52.403 million at December 31, 2025. Management expects to use existing working capital and may require future debt or equity financing.
- Large Equity Offering and Dilution
- The company entered into an ATM Sales Agreement on August 13, 2026 permitting issuance of up to $250.000 million of common shares, with agent commissions of up to 2.25% of gross proceeds, creating potential dilution. Common shares outstanding already increased to 194,250,599 from 187,354,424 at December 31, 2025.
- Permitting Delays Reduced Production
- Management reported that South Texas permitting delays reduced overall 2026 production estimates and that it reduced rig activity to align with operational needs. The TCEQ waste-disposal well permit was still expected in Q3 2026, while the first Upper Spring Creek wellfield was awaiting final authorization.
- Internal-Control Weaknesses Persist
- Disclosure controls and procedures remained ineffective as of June 30, 2026 because of previously reported material weaknesses in internal control over financial reporting. Management stated that the weaknesses will not be considered remediated until controls operate for a sufficient period and testing confirms effectiveness.
- No Formal Risk-Factor Changes
- The filing states that there were no material changes to the risk factors disclosed in the March 31, 2026 Form 10-K. Nonetheless, the new $250.000 million ATM facility materially increases the potential financing and dilution exposure described in the filing.
What they reported.
What the company itself reported, taken out of the document.
- Earnings per share
- $-0.21
- Gross margin
- -16.4%
- Operating margin
- -187.9%
- Segment
- Single reportable uranium extraction, recovery, sales and exploration segment: revenue was $15.696 million in Q2 2026, up 328% from $3.664 million in Q2 2025 and down 14% from $18.301 million in Q1 2026.
What they said about what is next.
No explicit numeric revenue or EPS guidance was provided. Management stated that permitting delays reduced overall production estimates for 2026, expects annualized savings from an approximately 20% headcount reduction beginning in April 2026, and anticipates further cost efficiencies as wellfield patterns come online. Management believes available cash, expected operating cash flows and potential financings will fund operations and scheduled debt service for the next twelve months.
The filing reads worse than the one before it.
What came before.
- 10-Q · May 14, 2026
- enCore Energy Corp. reported revenues of $18.3M in Q1 2026, a slight increase from $18.2M in Q1 2025, primarily due to an 8% rise in sales prices despite a decline in volume sold. The company recorded a net income of…
- 10-K · March 31, 2026
- enCore reported operational progress in 2025 with uranium extraction expanding (management states extraction increased "over 100% compared to the 2024 results") and the company produced a positive gross profit of…
- 10-Q · November 10, 2025
- enCore reported quarterly revenue of $8.876M and a gross profit of $3.891M, an improvement versus the prior-year quarter’s gross loss of $(1.342)M. Diluted net loss per share improved to $(0.03) from $(0.09) a year ago,…
- 10-Q · August 11, 2025
- enCore reported revenue of $3,664 (three months ended June 30, 2025) and a net loss attributable to enCore of $(6,326) (EPS $(0.03)). Gross profit was $1,130 for the quarter, driven in part by a $7,671 realized gain on…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing EU makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever